Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06093477 · ClinicalTrials.gov registry record · NA
Studying Melatonin and Recovery in Teens
A NA study of Spondylolisthesis and Kyphosis, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT06093477: Recruiting NA study of Spondylolisthesis and Kyphosis, sponsored by Stanford University.
NCT06093477 is a NA study of Spondylolisthesis and Kyphosis that is actively recruiting participants, run by Stanford University. The registered enrollment target is 45 participants, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06093477, a NA study of Spondylolisthesis and Kyphosis, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that may be effective in promoting longer, higher quality sleep. This study will assess the feasibility and acceptability of melatonin for teens undergoing major musculoskeletal surgery, as well as determine optimal measured outcomes (sleep, pain, health-related quality of life) at short- and long-term follow-up.
Primary Outcome
Youth will self-report daily medication administration on the morning and evening diaries, including the study drug as well as opioid and non-opioid analgesic medications. Medication administration will also be extracted from the EMR during hospitalization. Adherence will be measured as the percentages of doses taken.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fast-Dissolve Melatonin Pill
- OTHER Fast-Dissolve Placebo Pill
Study Locations (1)
California
- Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06093477 shows while recruiting
NCT06093477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (70% lower).
The record links to 8 conditions, with Spondylolisthesis appearing as the primary indexed condition, and to 2 interventions - of which Fast-Dissolve Melatonin Pill is the first listed.
NCT06093477 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06093477 about?
NCT06093477 is a clinical study titled "Studying Melatonin and Recovery in Teens". The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that may be effective in promoting longer, higher quality sleep. This study will assess the feasibility ...
What is the current status of trial NCT06093477?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-05-30. Estimated completion is 2028-03-31.
What conditions does trial NCT06093477 study?
This clinical trial studies the following conditions: Spondylolisthesis, Kyphosis, Scoliosis; Adolescence, Scoliosis Idiopathic, Hip Surgery.
What interventions are being tested in trial NCT06093477?
The interventions under investigation include: Fast-Dissolve Melatonin Pill (DIETARY_SUPPLEMENT), Fast-Dissolve Placebo Pill (OTHER).
Who is sponsoring clinical trial NCT06093477?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06093477 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spondylolisthesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06093477's enrollment target sits among peer trials
45 13th of 18 higher than 5 of 18 other Spondylolisthesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spondylolisthesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PREventing Pain After Surgery
RECRUITING · NA
-
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
RECRUITING · NA
-
Lumbar Fusion With Porous Versus Non-Porous Cages
ACTIVE NOT RECRUITING · NA
-
Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages
ACTIVE NOT RECRUITING · NA
-
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
ACTIVE NOT RECRUITING · NA
-
Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI